Arno Therapeutics

(OTC) ARNI

Current Price$0.00

Market CapN/A

Since IPO (2008)-100%

5 Year-100%

1 Year-99%

1 Month-100%

Arno Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$13.74M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.00

Volume

1,000

Open

$0.00

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

ARNI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Arno Therapeutics

Industry

Biotechnology

Sector

Health Care

Headquarters

Flemington, NJ 08822, US

ARNI Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

-32%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

49.35M

Volume

1.00K

Avg. Volume

Financials (TTM)

Gross Profit

$7.63K

Operating Income

$13.41M

EBITDA

$13.40M

Operating Cash Flow

$9.97M

Capital Expenditure

$0.00

Free Cash Flow

$9.97M

Cash & ST Invst.

$66.99K

Total Debt

$2.10M

Arno Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2016YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$3.85M

-466.3%

EBITDA

$3.85M

-33.9%

Quarterly Fundamentals

Name

Q3 2016YOY CHG

Net Cash

$2.12M

+1751.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$782.00

-84.6%

Short Term Debt

$4.31K

+16.0%

Return on Assets

-31.94%

N/A

Return on Invested Capital

3.47%

N/A

Free Cash Flow

$1.14M

+49.2%

Operating Cash Flow

$1.14M

+49.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PANCPanacos Pharmaceuticals, Inc.

PANCPanacos Pharmaceuticals, Inc.$0.00+0.00%

CALACalithera Biosciences, Inc.

CALACalithera Biosciences, Inc.$0.00+0.00%

TLOGTetraLogic Pharmaceuticals Corporation

TLOGTetraLogic Pharmaceuticals Corporation$0.00+0.00%

IVBTInnovation1 Biotech Inc.

IVBTInnovation1 Biotech Inc.$0.00+0.00%

BTTXBetter Therapeutics, Inc.

BTTXBetter Therapeutics, Inc.$0.00+0.00%

ONPHOncology Pharma Inc.

ONPHOncology Pharma Inc.$0.07-29.90%

BXRXQBaudax Bio, Inc.

BXRXQBaudax Bio, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About ARNI

What is the current price of Arno Therapeutics?

Arno Therapeutics is trading at N/A per share.

What is the 52-week range for Arno Therapeutics?

Over the past 52 weeks, Arno Therapeutics has traded between N/A and $0.00.

How much debt does Arno Therapeutics have?

Arno Therapeutics total debt is unavailable.

How much cash does Arno Therapeutics have on hand?

Arno Therapeutics does not have cash on hand data available.

What is Arno Therapeutics’s dividend yield?

Arno Therapeutics does not currently have a dividend yield.

Arno Therapeutics

Arno Therapeutics Financials at a Glance

ARNI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Arno Therapeutics

ARNI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Arno Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ARNI

What is the current price of Arno Therapeutics?

What is the 52-week range for Arno Therapeutics?

How much debt does Arno Therapeutics have?

How much cash does Arno Therapeutics have on hand?

What is Arno Therapeutics’s dividend yield?

Premium Investing Services